I couldn't be more pleased that [insert gratuitous but sincere praise:] outstanding Toronto Star writer Stuart Laidlaw has been rigorously following the Merck/Elsevier scandal. It's practically flattering that he's listening to bioethics' and in particular bioethics' publishing voices, and he's quoted The American Journal of Bioethics Editor's Blog [that'd be... (read the rest)
posted June 17, 2009
As the story continues to unfold in the Elsevier-Merck phony journal scandal, one can hardly believe that at some point in the process of creating an entire division of not one, not six, but now we have learned from The Scientist today, 9 journals in the "Australasian Journal of' series".... (read the rest)
posted June 4, 2009
In fact, they love them so much that they had an entire division devoted to making money off of the pharmaceutical industry's need to publish poser peer-reviewed journals and phony editorials, aka "advertorials". According to BoingBoing, Elsevier had an entire imprint comprised of 6 journals that were published for pharma.... (read the rest)
posted May 11, 2009
It's a safe guess that somewhere at Merck today someone is going through the meeting minutes of the day that the hair-brained scheme for the Australasian Journal of Bone and Joint Medicine was launched, and that everyone who was in the room is now going to be fired. The Scientist... (read the rest)
posted May 1, 2009
If you use an RSS reader, you can subscribe to a feed of all future entries from blog.bioethics.net tagged 'Merck'. [What is this?]
The American Journal of Bioethics is published by Taylor & Francis Health Sciences
The Blog is Funded in part by a grant from The Greenwall Foundation
(#5-39182 (8), "Bioethics Education Network"; PI: Glenn McGee)